SAM
XBI icon

Synergy Asset Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Synergy Asset Management’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$389K Buy
+2,459
New +$332K 0.04% 187
2022
Q3 		– Sell
-58,024
Closed -$4.31M – 141
2022
Q2 		$4.31M Buy
+58,024
New +$4.36M 1.14% 30

Other funds holding XBI

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
PR
PSP Research Newtown Square, Pennsylvania $188M AUM
AAS
Annex Advisory Services Brookfield, Wisconsin $5.86B AUM 21.83% 1-Year Est. Return
WAM
Weatherly Asset Management Del Mar, California $1.4B AUM 36.32% 1-Year Est. Return
RFM
Royal Fund Management Lady Lake, Florida $1.2B AUM 32.21% 1-Year Est. Return
MFS
Madrona Financial Services Everett, Washington $543M AUM 30.87% 1-Year Est. Return
SGH
Sivik Global Healthcare Greenwich, Connecticut $132M AUM 24.1% 1-Year Est. Return
EWM
Edge Wealth Management New York $594M AUM 24.92% 1-Year Est. Return
LHWM
Lake Hills Wealth Management Austin, Texas $220M AUM 39.11% 1-Year Est. Return
MWA
MFA Wealth Advisors Pittsburgh, Pennsylvania $587M AUM 27.44% 1-Year Est. Return

Synergy Asset Management's XBI Position: Q2 2026 in Review

Synergy Asset Management opened a new position in State Street SPDR S&P Biotech ETF (XBI) in Q2 2026: 2,459 shares worth $389K. The stake represents 0.04% of the portfolio and ranks #187 among its holdings. This is a return to the name: Synergy Asset Management previously reported a position in XBI as recently as Q2 2022.

Synergy Asset Management first reported a position in XBI in Q2 2022 and has held it in 2 quarters since. The position peaked at $4.31M in Q2 2022. 198 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

  • Synergy Asset Management held 2,459 shares of State Street SPDR S&P Biotech ETF worth $389K as of Q2 2026.
  • State Street SPDR S&P Biotech ETF was a new Synergy Asset Management position in Q2 2026.
  • State Street SPDR S&P Biotech ETF made up 0.04% of Synergy Asset Management's portfolio in Q2 2026, its #187 holding.
  • Synergy Asset Management first reported a position in State Street SPDR S&P Biotech ETF in Q2 2022 and has held it in 2 quarters since.
  • Synergy Asset Management's State Street SPDR S&P Biotech ETF position peaked at $4.31M in Q2 2022.
  • 198 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Synergy Asset Management's 13F filing for Q2 2026, filed 22 Jul 2026.